AI in Pharma: Compliance, Regulations & GxP Boundaries
Your roadmap to safe AI adoption: Regulations, risk management, and guidelines
Key Takeaways
These changes aren’t just regulatory formalities. They reshape what compliance looks like across IT, QA and data science – and place new demands on your teams, processes and suppliers.

How to apply risk assessments and “human-in-the-loop” safeguards
Practical, compliance-driven use cases, including Cegeka’s Quality Impact Recall Agent
Key do’s and don’ts for using AI in regulated environments
AI is transforming Pharma and MedTech, but compliance defines the boundaries. As regulations evolve, the key question is: How and where can AI be leveraged safely within the context of your business processes?
In this webinar, experts from Cegeka and Epista cut through the complexity to explain upcoming regulations, risk assessment principles, and human-in-the-loop safeguards. We’ll share practical examples, including Cegeka’s Quality Impact Recall Agent, and outline the do’s and don’ts for AI in regulated environments.
Join us to learn how to balance innovation with regulatory rigor.


